41 studies found for:
Open Studies | "Adenoviridae Infections"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Recruiting |
IMPACT Canadian Rotavirus Surveillance of Hospitalizations and Emergency Department Visits
|
||||
| 22 | Recruiting |
Intranasal AD4-H5-VTN as an Adenovirus Vaccine
|
||||
| 23 | Recruiting |
Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
|
||||
| 24 | Unknown † |
Adjuvant Adenovirus-Thymidine Kinase Enzyme (ADV-TK) Gene Therapy Improves Survival in Patients With Gliomas
|
||||
| 25 | Unknown † |
Gene Therapy for Prostate Cancer That Returns After Radiation Therapy
|
||||
| 26 | Recruiting |
CGTG-102 for Therapy of Advanced Cancers
|
||||
| 27 | Unknown † |
Trial of E10A in Head and Neck Cancer
|
||||
| 28 | Unknown † |
Study of Treatment and Metabolism in Patients With Urea Cycle Disorders
|
||||
| 29 | Recruiting |
GVAX vs. Placebo for MDS/AML After Allo HSCT
|
||||
| 30 | Not yet recruiting |
Administration of AdVEGF-All6A+ to Myocardium of Individuals With Diffuse CAD Via Minimally Invasive Surgery
|
||||
| 31 | Recruiting |
RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections.
|
||||
| 32 | Recruiting |
A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer
|
||||
| 33 | Recruiting |
Experimental AD4-H5-VTN Vaccine in Healthy Volunteers
|
||||
| 34 | Recruiting |
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
|
||||
| 35 | Recruiting |
Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients
|
||||
| 36 | Recruiting |
Study of a New MVA Vaccine for Hepatitis C Virus
|
||||
| 37 | Recruiting |
Ad5.hAC6 Gene Transfer for CHF
|
||||
| 38 | Unknown † |
Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma
|
||||
| 39 | Recruiting |
Viral Infections in Healthy and Immunocompromised Hosts
|
||||
| 40 | Recruiting |
Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors.
|
† Indicates status has not been verified in more than two years

